Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence.

No abstract is available for this paper.

• Publication year

  1973

• Venue

  Gastroenterology

• Publication date

  1973-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0016-5085(19)33138-5PMID 4124404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification and immunochemical characterization of group II pepsinogens in human seminal fluid.

  1972cited by this paper
• Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence.

  1971cited by this paper
• Immunologic studies of human group I pepsinogens.

  1971cited by this paper
• Pepsinogens, pepsins, and pepsin inhibitors.

  1971cited by this paper
• Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence.

  1971cited by this paper
• Electrophoretic heterogeneity and relationships of pepsinogens in human urine, serum, and gastric mucosa.

  1970cited by this paper
• Slow moving protease and the seven pepsinogens. Electrophoretic demontration of the existence of eight proteolytic fractions in human gastric mucosa.

  1969cited by this paper
• Slow moving protease and the seven pepsinogens. Electrophoretic demontration of the existence of eight proteolytic fractions in human gastric mucosa.

  1969cited by this paper
• pH of the duodenum of patients with and without duodenal ulcers measured with a radiotelemetering capsule.

  1969cited by this paper
• The fine structure of Brunner's glands in man.

  1968cited by this paper
• The normal human gastric epithelia. A fine structural study.

  1968cited by this paper
• Electrophoretic and Functional Heterogeneity of Pepsinogen in Several Species

  1966cited by this paper
• Studies on the secretion and motility of Brunner's gland pouches.

  1966cited by this paper
• LOCALIZATION BY IMMUNOFLUORESCENCE OF AMYLASE, TRYPSINOGEN AND CHYMOTRYPSINOGEN IN THE ACINAR CELLS OF THE PIG PANCREAS

  1966cited by this paper
• Profile of pH, pressure, and potential difference at gastroduodenal junction in man.

  1965cited by this paper
• ELECTROPHORETIC AND IMMUNOCHEMICAL DEMONSTRATION OF THE EXISTENCE OF FOUR HUMAN PEPSINOGENS.

  1964cited by this paper
• SEPARATION OF PEPSIN I, PEPSIN II A, PEPSIN II B, AND PEPSIN III FROM HUMAN GASTRIC MUCOSA.

  1963cited by this paper
• SEPARATION OF PEPSINOGEN I, PEPSINOGEN II, AND PEPSINOGEN III FROM HUMAN GASTRIC MUCOSA.

  1963cited by this paper
• A PARAFFIN EMBEDDING TECHNIQUE FOR STUDIES EMPLOYING IMMUNOFLUORESCENCE

  1962cited by this paper
• Textbook of Medical Physiology

  1961cited by this paper
• Secretion of pepsinogen by the pyloric glands of the dog, with some observations on the histology of the gastric mucosa.

  1960cited by this paper
• Principles of Biochemistry

  1955cited by this paper

• Validation of the ABC Method for Gastric Cancer Risk Stratification Across Helicobacter pylori Infections With Diverse CagA Status and Subtypes in Brazil

  2025cites this paper
• Assessing Serum Pepsinogen and Helicobacter pylori Tests for Detecting Diffuse-Type Gastric Cancer: Insights from a Large-Scale and Propensity-Score-Matched Study in Republic of Korea

  2025cites this paper
• Protein Biomarkers of Gastric Preneoplasia and Cancer Lesions in Blood: A Comprehensive Review

  2024cites this paper
• Endoscopic and Histological Gastritis in University Students with Helicobacter pylori Infection

  2024cites this paper
• Chronic Atrophic Gastritis and Intestinal Metaplasia: A Latin American Perspective

  2024cites this paper
• How to Improve the Efficacy of Gastric Cancer Screening?

  2023cites this paper
• A Global Perspective on Gastric Cancer Screening: Which Concepts Are Feasible, and When?

  2023cites this paper
• The prediction model of operative link on gastric intestinal metaplasia stage III-IV: A multicenter study

  2023cites this paper
• Atrophic gastritis is inversely associated with gastroesophageal reflux disease in a twin register based study

  2022cites this paper
• Screening for gastric cancer in China: Advances, challenges and visions

  2021cites this paper
• Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method

  2021cites this paper
• Seroprevalence of Helicobacter pylori/CagA Antibodies in Guatemalan Gastric Cancer Patients: Association of Seropositivity with Increased Plasma Levels of Pepsinogens but not Soluble Urokinase Plasminogen Activator Receptor.

  2020cites this paper
• Associations of Helicobacter pylori seropositivity and gastric inflammation with pediatric asthma

  2020cites this paper
• Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults

  2020cites this paper
• Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children

  2020cites this paper
• Association between serum pepsinogen and atherosclerotic cardiovascular disease.

  2020cites this paper
• Clostridium difficile‐associated disease and Helicobacter pylori seroprevalence: A case‐control study

  2019cites this paper
• Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study

  2019cites this paper
• Gastrointestinal Toxicity Biomarkers

  2019cites this paper
• Prevalence and determinants of serological evidence of atrophic gastritis among Arab and Jewish residents of Jerusalem: a cross-sectional study

  2019cites this paper
• Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening

  2018cites this paper
• Predicting the Development of Gastric Neoplasms in a Healthcare Cohort by Combining Helicobacter pylori Antibodies and Serum Pepsinogen: A 5-Year Longitudinal Study

  2018cites this paper
• Associations of Helicobacter pylori infection and peptic disease with diabetic mellitus: Results from a large population-based study

  2017cites this paper
• Human Serum Protein Markers for Gastric Cancer Detection

  2017cites this paper
• [Serological Changes after Equivocal Helicobacter pylori-serology Test Findings Dependent on Gastric Secreting Ability].

  2017cites this paper
• Evaluation of Pepsinogen I as a Biomarker of Drug-induced Gastric Mucosal Injury in Cynomolgus Monkeys

  2017influential citation
• Chapter 6 Helicobacter pylori Infection and Diabetes Mellitus

  2017cites this paper
• Helicobacter pylori infection, serum pepsinogens, and pediatric abdominal pain: a pilot study

  2017cites this paper
• The Impact of Gastric Atrophy on the Incidence of Diabetes

  2017cites this paper
• Long-term follow-up of pepsinogen I/II ratio after eradication of Helicobacter pylori in patients who underwent endoscopic mucosal resection for gastric cancer.

  2017cites this paper
• Helicobacter pylori Infection and Diabetes Mellitus

  2016cites this paper
• Method evaluation of pepsinogen I/II assay based on chemiluminescent immunoassays and comparison with other test methods.

  2016cites this paper
• Actual Status of Involvement of Helicobacter pylori Infection That Developed Gastric Cancer from Group A of ABC (D) Stratification - Study of Early Gastric Cancer Cases That Underwent Endoscopic Submucosal Dissection

  2016cites this paper
• Increased Serum Pepsinogen II Level as a Marker of Pangastritis and Corpus-Predominant Gastritis in Gastric Cancer Prevention.

  2016cites this paper
• Pepsinogen-II 100 bp ins/del gene polymorphism and its elevated circulating levels are associated with gastric cancer, particularly with Helicobacter pylori infection and intestinal metaplasia

  2016cites this paper
• Screening and surveillance for gastric cancer in the United States: Is it needed?

  2016cites this paper
• Helicobacter pylori Infection Status Correlates with Serum Parameter Levels Responding to Multi-organ Functions

  2015cites this paper
• Helicobacter pylori Antibody Titer and Gastric Cancer Screening

  2015cites this paper
• Is screening and surveillance for early detection of gastric cancer needed in Korean Americans?

  2015cites this paper
• Identification of a high-risk group for low-dose aspirin-induced gastropathy by measuring serum pepsinogen in H. pylori-infected subjects

  2015cites this paper
• Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: A longitudinal study

  2015cites this paper
• The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis.

  2015cites this paper
• Low Pepsinogen I Level Predicts Multiple Gastric Epithelial Neoplasias for Endoscopic Resection

  2014cites this paper
• Secondary Prevention of Epidemic Gastric Cancer in the Model of Helicobacter pylori-Associated Gastritis

  2014cites this paper
• Cutoff serum pepsinogen values for predicting gastric acid secretion status.

  2014cites this paper
• False Sero-Negative Results for Helicobacter Pylori Infection Indicate Increased Risk of Severe Atrophic Gastritis in Japanese Patients

  2014cites this paper
• Digestive Function of the Stomach

  2014cites this paper
• Pepsinogen II Can Be a Potential Surrogate Marker of Morphological Changes in Corpus before and after H. pylori Eradication

  2014cites this paper
• Anti-Helicobacter pylori activities of FEMY-R7 composed of fucoidan and evening primrose extract in mice and humans

  2014cites this paper
• Intestinal Metaplasia: Reversible after Treatment?

  2013cites this paper
• Are the serum biomarkers pepsinogen I and II good predictors for the detection of subjects with atrophic gastritis in areas that have different gastric cancer incidence?

  2013cites this paper
• Development of diffuse carcinomas in the gastric corpus in patients with rugal hyperplastic gastritis

  2013cites this paper
• Oxidative phosphorylation in different diseases of gastric mucosa

  2013cites this paper
• Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori

  2013cites this paper
• Examination of serum pepsinogen in functional dyspepsia.

  2012cites this paper
• Changing Trends of Serum Pepsinogen I/II Ratio in Asymptomatic Subjects

  2012cites this paper
• Association between HIV infection and Gastric Cancer in an African Population

  2012cites this paper
• Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the residents of two cities in china with distinct mortality rates of gastric cancer.

  2012cites this paper
• Serum Pepsinogen II as a Good Marker for Mass Screening and Eradication of H. pylori Infection in Populations at risk for Gastric Cancer

  2012cites this paper
• Gastric Adenocarcinoma of Fundic Gland Type: Report of Three Cases

  2012cites this paper
• Recent development of gastric cancer prevention.

  2012cites this paper
• Serum pepsinogen and Helicobacter pylori infection—a Japanese population study

  2012cites this paper
• Exocrine gastric secretion and gastritis: pathophysiological and clinical relationships.

  2011cites this paper
• Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.

  2011cites this paper
• Low serum levels of pepsinogen and gastrin 17 are predictive of extensive gastric atrophy with high-risk of early gastric cancer.

  2011cites this paper
• Review article: methods of measuring gastric acid secretion

  2011cites this paper
• Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method”

  2011cites this paper
• Predictive Power of Serum Pepsinogen Tests for the Development of Gastric Cancer in Comparison to the Histologic Risk Index

  2010cites this paper
• Validation of the pepsinogen test method for gastric cancer screening using a follow-up study

  2009cites this paper
• Barrett's esophagus is characterized by the absence of Helicobacter pylori infection and high levels of serum pepsinogen I concentration in Japan

  2009cites this paper
• Biliary Obstruction and Pancreatitis Caused by Diffuse Nodular Hyperplasia of Brunner’s Gland

  2009cites this paper
• Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication

  2009cites this paper
• Association of Helicobacter pylori infection with chronic atrophic gastritis: Meta‐analyses according to type of disease definition

  2008cites this paper
• Upper gastrointestinal adenocarcinoma : associations with gastric secretory function and gender

  2008influential citation
• Non-invasive tests in gastric diseases.

  2008cites this paper
• Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: Implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy

  2008cites this paper
• Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.

  2008cites this paper
• [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].

  2008cites this paper
• Brunner’s Gland Hyperplasia: A Rare Cause for Gastric Outlet Obstruction

  2008cites this paper
• Studies on acid protease fractions and gastric mucosal atrophy. 3. special reference to peptic ulcers

  2007cites this paper
• Studies on the pepsinogens of human gastric mucosal extracts

  2007cites this paper
• Non-invasive assessment of chronic liver and gastric diseases.

  2007cites this paper
• Serum pepsinogen and gastric cancer screening.

  2007influential citation
• Changes in the antral mucosal pepsin in dogs with chronic ulcer: Pathogenesis of cinchophen ulcer

  2007cites this paper
• Studies on acid protease fractions and gastric mucosal atrophy

  2007cites this paper
• Using serum pepsinogens wisely in a clinical practice

  2007cites this paper
• Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression

  2007cites this paper
• Gastric outlet obstruction caused by Brunner's gland hyperplasia: case report and review of literature.

  2006cites this paper
• Stomach Cancer Afier Total Gastrectomy

  2006cites this paper
• Leading articles Mucus, pepsin, and peptic ulcer

  2006cites this paper
• Vitamin B12 and folate depletion in the elderly. Diagnosis, clinical correlates and causes

  2006cites this paper
• Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori

  2006cites this paper
• Characterization of urinary peptic activity after total gastrectomy

  2006cites this paper
• Immunolocalisation of cathepsin D in normal and neoplastic human tissues kidney

  2005cites this paper
• Gastric antibacterial efficiency is different for pepsin A and C

  2005cites this paper
• Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and -positive Japanese subjects

  2005cites this paper
• Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study

  2005cites this paper
• THE JOURNAL OF HISTOCHEMISTRY AND CYTOCHEMISTRY

  2005cites this paper
• Upper Gastrointestinal Tract

  2005cites this paper
• Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach.

  2005cites this paper